Product Safety Recalls

Product Recall Tracker

INSULIN LISPRO Recall D-0882-2022

Description: Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59

INSULIN LISPRO Recall D-0882-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0882-2022
Event ID89976
BrandHUMALOG
Generic NameINSULIN LISPRO
ManufacturerINSULIN LISPRO
Original Package?1
Active SubstanceINSULIN LISPRO
Drug RouteINTRAVENOUS
DistributionNM only
Quantity1 box
Recall ReasonTEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
Drug ClassificationClass I
Drug Code Info20220525
Product NDC0002-8799 0002-7510 0002-7516
Product NUIN0000004931 N0000175453
Drug UPC0300027510019
Pharma Class (EPC)Insulin Analog [EPC]
Pharma Class (CS)Insulin [Chemical/Ingredient]
Recall Initiation Date20220405
Report Date20220525
Classification Date20220519
Address7000 Cardinal Pl
Dublin, OH 43017-1091
United States
Recalling FirmCardinal Health Inc.
Initial Notification Letter
Unique Ingredient IdentifierGFX7QIS1II
Drug Application NumberBLA020563
Structured Product Labeling (SPL ID)28413b62-921e-4eb4-bd8b-cf17d752a448
Structured Product Labeling (SPL Set ID)c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.